Quanterix Corp
(NAS:QTRX)
$
12.47
0.41 (3.4%)
Market Cap: 478.59 Mil
Enterprise Value: 221.31 Mil
PE Ratio: 0
PB Ratio: 1.42
GF Score: 70/100 Quanterix Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021 / 07:50PM GMT
Release Date Price:
$67.17
(+8.37%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Sorry, some mute problems there. I am Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Quanterix to our conference this afternoon. We have Kevin Hrusovsky, the Chairman and Chief Executive Officer of Quanterix. Kevin, thanks so much for joining us.
E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO
Our pleasure, Matt. Thank you.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. And I thought maybe I'd just turn it over to you to just briefly. Just maybe talk about -- set the stage and maybe talk a little bit about Quanterix, the platform, and where you see the company sort of in the near and long term?
E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO
Absolutely. Thanks, Matt. Yes, we're a disruptive technology company that
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot